Published in N Engl J Med on September 03, 1987
Myocardial infarction: the first 24 hours. Br Med J (Clin Res Ed) (1988) 3.74
Training for coronary angioplasty. BMJ (1989) 1.70
Safety and efficacy of repeat thrombolytic treatment after acute myocardial infarction. Br Heart J (1990) 1.54
Immediate angioplasty after thrombolysis: a systematic review. CMAJ (2005) 1.45
Percutaneous Coronary Intervention after Fibrinolysis for ST-Segment Elevation Myocardial Infarction Patients: An Updated Systematic Review and Meta-Analysis. PLoS One (2015) 1.38
British Heart Foundation surveys (1987 and 1989) of United Kingdom treatment policies for acute myocardial infarction. Br Heart J (1991) 1.33
Answers to complex questions cannot be derived from "simple" trials. Br Heart J (1992) 1.04
Coronary revascularization after thrombolytic therapy for myocardial infarction: what caseloads could Canadian centres face? CMAJ (1989) 1.01
A randomised dose ranging study of recombinant tissue plasminogen activator in acute myocardial infarction. Br Med J (Clin Res Ed) (1988) 0.91
Comparison of five cardiac markers in the detection of reperfusion after thrombolysis in acute myocardial infarction. Br Heart J (1995) 0.89
Primary angioplasty. Br Heart J (1995) 0.89
Which patients should have exercise testing after myocardial infarction treated by thrombolysis? Br Heart J (1993) 0.86
Health related quality of life after conservative or invasive treatment of inducible postinfarction ischaemia. DANAMI study group. Heart (2000) 0.86
Association of coronary atherosclerotic burden with clinical presentation and prognosis in patients with stable and unstable coronary artery disease. Clin Res Cardiol (2012) 0.85
Outcomes research in the development and evaluation of practice guidelines. BMC Health Serv Res (2002) 0.85
Rescue PTCA Following Failed Thrombolysis and Primary PTCA: A Retrospective Study of Angiographic and Clinical Outcome. J Thromb Thrombolysis (1997) 0.82
Recommendations on percutaneous coronary intervention for the reperfusion of acute ST elevation myocardial infarction. Heart (2004) 0.82
Diagnosis and management of acute ischemic stroke: speed is critical. CMAJ (2015) 0.80
Should all patients with an acute myocardial infarction be referred for direct PTCA? Heart (2004) 0.80
Early and long-term outcome of elective stenting of the infarct-related artery in patients with viability in the infarct-area: Rationale and design of the Viability-guided Angioplasty after acute Myocardial Infarction-trial (The VIAMI-trial). Curr Control Trials Cardiovasc Med (2004) 0.79
The use of percutaneous transluminal coronary angioplasty in myocardial infarction. Tex Heart Inst J (1991) 0.79
Thrombolytic therapy for myocardial infarction: the problem, the promise and the price. CMAJ (1988) 0.78
A Double-Blind Multicenter Comparison of the Efficacy and Safety of Saruplase and Urokinase in the Treatment of Acute Myocardial Infarction: Report of the SUTAMI Study Group. J Thromb Thrombolysis (1995) 0.78
Prognostic significance of nonfatal myocardial reinfarction in survivors of a first infarction. Neth Heart J (2001) 0.77
Reverse redistribution on Tl-201 SPECT images after reperfusion therapy for acute myocardial infarction: possible mechanism and prognostic implications. Heart Vessels (1992) 0.77
Revascularization therapy for coronary artery disease. Coronary artery bypass grafting versus percutaneous transluminal coronary angioplasty. Tex Heart Inst J (1995) 0.77
Percutaneous transluminal coronary angioplasty: what next? Br Heart J (1990) 0.77
Pseudoaneurysm of the femoral artery after cardiac catheterisation: diagnosis and treatment by manual compression guided by Doppler colour flow imaging. Br Heart J (1994) 0.77
Contrast echocardiography accurately predicts myocardial perfusion before angiography during acute myocardial infarction. Can J Cardiol (2007) 0.76
Primary coronary angioplasty in patients with acute myocardial infarction. Tex Heart Inst J (1994) 0.76
Is thrombolysis alone the best therapy for acute myocardial infarction? Current status and emerging strategies. Tex Heart Inst J (1991) 0.76
Early interventions in the management of acute uncomplicated myocardial infarction. West J Med (1995) 0.75
Thrombolytic therapy in acute myocardial infarction. Postgrad Med J (1988) 0.75
Efficacy of delayed percutaneous transluminal coronary angioplasty after intravenous use of streptokinase in myocardial infarction. CMAJ (1988) 0.75
After thrombolytic therapy: angiography, angioplasty, or surgery? Tex Heart Inst J (1990) 0.75
Therapeutic options in treating acute myocardial infarction. West J Med (1989) 0.75
Aggressive management of acute myocardial infarction. J Natl Med Assoc (1988) 0.75
Efficacy of a new mutated recombinant tissue-type plasminogen activator in beagles with acute coronary artery thrombi. World J Emerg Med (2010) 0.75
Myocardial protection during surgical intervention for treatment of acute myocardial infarction. Tex Heart Inst J (1992) 0.75
Thrombolytic therapy for acute myocardial infarction. West J Med (1989) 0.75
Consequences of variation in treatment for acute myocardial infarction. Health Serv Res (1990) 0.75
Early, Complete Infarct Vessel Patency: Arriving at a Gold Standard for Future Clinical Investigation in Myocardial Reperfusion. J Thromb Thrombolysis (1997) 0.75
Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med (1996) 46.18
The effectiveness of right heart catheterization in the initial care of critically ill patients. SUPPORT Investigators. JAMA (1996) 17.62
Evaluating the yield of medical tests. JAMA (1982) 14.05
Risk of cardiovascular events associated with selective COX-2 inhibitors. JAMA (2001) 13.93
An amino acid liquid synthetic medium for the development of mycelial and yeast forms of Candida Albicans. Sabouraudia (1975) 11.53
A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators. N Engl J Med (1999) 10.17
Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. The SOLVD Investigattors. N Engl J Med (1992) 8.38
Clinical judgment and statistics. Lessons from a simulated randomized trial in coronary artery disease. Circulation (1980) 7.96
Effect of nesiritide in patients with acute decompensated heart failure. N Engl J Med (2011) 7.62
Effect of enalapril on myocardial infarction and unstable angina in patients with low ejection fractions. Lancet (1992) 7.22
Regression modelling strategies for improved prognostic prediction. Stat Med (1984) 7.09
Use of medical resources and quality of life after acute myocardial infarction in Canada and the United States. N Engl J Med (1994) 6.78
A comparison of low-molecular-weight heparin with unfractionated heparin for unstable coronary artery disease. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q-Wave Coronary Events Study Group. N Engl J Med (1997) 6.19
Cardiac troponin T levels for risk stratification in acute myocardial ischemia. GUSTO IIA Investigators. N Engl J Med (1996) 5.94
Racial variation in the use of coronary-revascularization procedures. Are the differences real? Do they matter? N Engl J Med (1997) 5.80
Value of the history and physical in identifying patients at increased risk for coronary artery disease. Ann Intern Med (1993) 5.59
Outcome of acute myocardial infarction according to the specialty of the admitting physician. N Engl J Med (1996) 5.51
A brief self-administered questionnaire to determine functional capacity (the Duke Activity Status Index). Am J Cardiol (1989) 5.50
Acute renal failure after coronary intervention: incidence, risk factors, and relationship to mortality. Am J Med (1997) 4.88
Relationship of depression to increased risk of mortality and rehospitalization in patients with congestive heart failure. Arch Intern Med (2001) 4.85
Sex, clinical presentation, and outcome in patients with acute coronary syndromes. Global Use of Strategies to Open Occluded Coronary Arteries in Acute Coronary Syndromes IIb Investigators. N Engl J Med (1999) 4.53
Coronary angioplasty with or without stent implantation for acute myocardial infarction. Stent Primary Angioplasty in Myocardial Infarction Study Group. N Engl J Med (1999) 4.37
Regional variation across the United States in the management of acute myocardial infarction. GUSTO-1 Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries. N Engl J Med (1995) 4.29
Cost effectiveness of early discharge after uncomplicated acute myocardial infarction. N Engl J Med (2000) 4.19
1999 update: ACC/AHA guidelines for the management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction). J Am Coll Cardiol (1999) 4.15
Cardiologist versus internist management of patients with unstable angina: treatment patterns and outcomes. J Am Coll Cardiol (1995) 4.10
Regression models in clinical studies: determining relationships between predictors and response. J Natl Cancer Inst (1988) 4.07
Management of heart failure. I. Pharmacologic treatment. JAMA (1994) 4.07
Aortocoronary saphenous vein graft disease: pathogenesis, predisposition, and prevention. Circulation (1998) 3.92
Marked inflammatory sequelae to implantation of biodegradable and nonbiodegradable polymers in porcine coronary arteries. Circulation (1996) 3.82
Association between myeloperoxidase levels and risk of coronary artery disease. JAMA (2001) 3.74
Multiple complex coronary plaques in patients with acute myocardial infarction. N Engl J Med (2000) 3.70
Cost effectiveness of thrombolytic therapy with tissue plasminogen activator as compared with streptokinase for acute myocardial infarction. N Engl J Med (1995) 3.69
Prognostic value of a treadmill exercise score in outpatients with suspected coronary artery disease. N Engl J Med (1991) 3.63
Predictors of outcome in patients with acute coronary syndromes without persistent ST-segment elevation. Results from an international trial of 9461 patients. The PURSUIT Investigators. Circulation (2000) 3.61
Coronary morphologic and clinical determinants of procedural outcome with angioplasty for multivessel coronary disease. Implications for patient selection. Multivessel Angioplasty Prognosis Study Group. Circulation (1990) 3.49
Referral patterns for coronary artery disease treatment: gender bias or good clinical judgment? Ann Intern Med (1992) 3.39
Predictors of 30-day mortality in the era of reperfusion for acute myocardial infarction. Results from an international trial of 41,021 patients. GUSTO-I Investigators. Circulation (1995) 3.38
Outmigration for coronary bypass surgery in an era of public dissemination of clinical outcomes. Circulation (1996) 3.32
Scorecard cardiovascular medicine. Its impact and future directions. Ann Intern Med (1994) 3.32
"Atypical" depression following childbirth. Br J Psychiatry (1968) 3.32
Angiotensin-converting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease. The TREND (Trial on Reversing ENdothelial Dysfunction) Study. Circulation (1996) 3.28
Job strain and the prevalence and outcome of coronary artery disease. Circulation (1995) 3.22
Resuscitation preferences among patients with severe congestive heart failure: results from the SUPPORT project. Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments. Circulation (1998) 3.11
The SUPPORT prognostic model. Objective estimates of survival for seriously ill hospitalized adults. Study to understand prognoses and preferences for outcomes and risks of treatments. Ann Intern Med (1995) 3.08
Prognostic importance of social and economic resources among medically treated patients with angiographically documented coronary artery disease. JAMA (1992) 3.06
Profile and prevalence of aspirin resistance in patients with cardiovascular disease. Am J Cardiol (2001) 2.99
Iatrogenic coronary artery dissections extending into and involving the aortic root. Catheter Cardiovasc Interv (2000) 2.94
Clinical data bases. Accomplishments and unrealized potential. Med Care (1985) 2.83
Determinants of the use of coronary angiography and revascularization after thrombolysis for acute myocardial infarction. N Engl J Med (1996) 2.83
ACC/AHA guidelines for the management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction). J Am Coll Cardiol (1996) 2.81
Difference in countries' use of resources and clinical outcome for patients with cardiogenic shock after myocardial infarction: results from the GUSTO trial. Lancet (1997) 2.80
Electrophysiologic testing to identify patients with coronary artery disease who are at risk for sudden death. Multicenter Unsustained Tachycardia Trial Investigators. N Engl J Med (2000) 2.80
Thallium-201 for myocardial imaging. Relation of thallium-201 to regional myocardial perfusion. Circulation (1975) 2.77
Regression models for prognostic prediction: advantages, problems, and suggested solutions. Cancer Treat Rep (1985) 2.76
Medical care costs and quality of life after randomization to coronary angioplasty or coronary bypass surgery. Bypass Angioplasty Revascularization Investigation (BARI) Investigators. N Engl J Med (1997) 2.65
Emerging role of angiotensin-converting enzyme inhibitors in cardiac and vascular protection. Circulation (1994) 2.61
Comparison of predictions based on observational data with the results of randomized controlled clinical trials of coronary artery bypass surgery. J Am Coll Cardiol (1988) 2.59
Link between the angiographic substudy and mortality outcomes in a large randomized trial of myocardial reperfusion. Importance of early and complete infarct artery reperfusion. GUSTO-I Investigators. Circulation (1995) 2.53
Patient-specific predictions of outcomes in myocardial infarction for real-time emergency use: a thrombolytic predictive instrument. Ann Intern Med (1997) 2.52
Characterization of cDNA sequences corresponding to three distinct HMG-1 mRNA species in line CHO Chinese hamster cells and cell cycle expression of the HMG-1 gene. Nucleic Acids Res (1987) 2.51
Factors affecting sensitivity and specificity of exercise electrocardiography. Multivariable analysis. Am J Med (1984) 2.49